Beranda › Kanker Darah › Distrik Columbia
Uji klinis Kanker Darah di Distrik Columbia
7 studi untuk Kanker Darah mencari peserta di lokasi di Distrik Columbia.
Kota di Distrik Columbia
Teks studi resmi (Bahasa Inggris)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- MedStar Georgetown University Hospital, Washington D.C.
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT03816345Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
- Childrens National Medical Center, Washington D.C.
Menerima pesertaFase 1
6 Months – 80 Years · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT02203903Mosaic Trial for Stem Cell Transplant Recipients
- Georgetown University School of Medicine, Washington D.C.
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06960993A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Children's National Medical Center, Washington D.C.
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- George Washington University, Washington D.C.
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT05663502Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's National Medical Center, Washington D.C.
Menerima pesertaFase 1
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 6 Des 2024 · NCT05476770Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.